Antibe Therapeutics
Stock Forecast, Prediction & Price Target
Antibe Therapeutics Financial Estimates
Antibe Therapeutics Revenue Estimates
Antibe Therapeutics EBITDA Estimates
Antibe Therapeutics Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 3/31/2019 | 3/31/2021 | 3/31/2022 | 3/31/2026 | 3/31/2027 | 3/31/2028 | |
Revenue
% change YoY
| CA$9.53M N/A | CA$9.71M 1.82% | CA$0 -100% | Avg: CA$6.52M Low: CA$6.52M High: CA$6.52M avg. 0% | Avg: CA$13.17M Low: CA$13.17M High: CA$13.17M avg. 101.99% | Avg: CA$16.62M Low: CA$16.62M High: CA$16.62M avg. 26.25% | |
Net Income
% change YoY
| CA$-12.81M N/A | CA$-26.30M -105.21% | CA$-25.05M 4.73% | Avg: CA$-23.76M Low: CA$-23.52M High: CA$-23.52M avg. 5.14% | Avg: CA$-24.95M Low: CA$-24.57M High: CA$-24.57M avg. -4.99% | Avg: CA$-4.18M Low: CA$-4.18M High: CA$-4.18M avg. 83.23% | |
EBITDA
% change YoY
| CA$-11.74M N/A | CA$-23.73M -102.14% | CA$-25.14M -5.96% | Avg: CA$-1.30M Low: CA$-1.30M High: CA$-1.30M avg. 94.81% | Avg: CA$-2.63M Low: CA$-2.63M High: CA$-2.63M avg. -101.99% | Avg: CA$-3.32M Low: CA$-3.32M High: CA$-3.32M avg. -26.25% | |
EPS
% change YoY
| -$0.6 N/A | -$0.71 -18.33% | -$0.49 30.98% | Avg: -$0.45 Low: -$0.45 High: -$0.45 avg. 8.16% | Avg: -$0.47 Low: -$0.47 High: -$0.47 avg. -4.44% | Avg: -$0.08 Low: -$0.08 High: -$0.08 avg. 82.97% | |
Operating Expenses
% change YoY
| CA$15.73M N/A | CA$27.81M 76.72% | CA$25.52M -8.20% | Avg: CA$7.67M Low: CA$7.67M High: CA$7.67M avg. -69.95% | Avg: CA$15.49M Low: CA$15.49M High: CA$15.49M avg. 101.99% | Avg: CA$19.56M Low: CA$19.56M High: CA$19.56M avg. 26.25% | |
FAQ
What is Antibe Therapeutics stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 27.79% in 2026-2028.
We have gathered data from 1 analysts. Their low estimate is -23.52M, average is -23.76M and high is -23.52M.
What is Antibe Therapeutics stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 42.74% in 2026-2028.
We have gathered data from 1 analysts. Their low revenue estimate is CA$6.52M, average is CA$6.52M and high is CA$6.52M.
What is Antibe Therapeutics stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 28.89% in 2026-2028.
We have gathered data from 1 analysts. Their low earnings per share estimate is -$0.45, average is -$0.45 and high is CA$-0.45.